Grantham, Mayo, Van Otterloo & Co (GMO)
CHE icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Chemed CHE Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,500
Closed -$1.08M – 761
2020
Q1 		$1.08M Buy
+2,500
New +$1.12M 0.01% 484
2018
Q2 		– Sell
-2,000
Closed -$546K – 563
2018
Q1 		$546K Hold
2,000
– – ﹤0.01% 474
2017
Q4 		$486K Sell
2,000
-14,807
-88% -$3.36M ﹤0.01% 460
2017
Q3 		$3.4M Sell
16,807
-9,000
-35% -$1.77M 0.02% 273
2017
Q2 		$5.28M Sell
25,807
-8,200
-24% -$1.63M 0.03% 236
2017
Q1 		$6.21M Sell
34,007
-16,705
-33% -$2.91M 0.04% 215
2016
Q4 		$8.13M Sell
50,712
-27,043
-35% -$3.97M 0.04% 208
2016
Q3 		$11M Sell
77,755
-37,122
-32% -$5.17M 0.05% 196
2016
Q2 		$15.7M Buy
114,877
+32,477
+39% +$4.31M 0.06% 190
2016
Q1 		$11.2M Buy
82,400
+58,500
+245% +$7.91M 0.04% 230
2015
Q4 		$3.58M Buy
+23,900
New +$3.53M 0.01% 288
2014
Q2 		– Sell
-33,147
Closed -$2.96M – 506
2014
Q1 		$2.96M Buy
+33,147
New +$2.7M 0.01% 363

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CHE Position: Q2 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Chemed (CHE) in Q2 2020, closing a stake of 2,500 shares — an estimated $1.08M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CHE in Q1 2014 and held it in 12 quarters. The position peaked at $15.7M in Q2 2016. 425 funds tracked by Wall St. Rank hold CHE as of Q2 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Chemed position as of Q2 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 2,500 Chemed shares in Q2 2020, an estimated $1.08M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Chemed in Q1 2014 and held it in 12 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Chemed position peaked at $15.7M in Q2 2016.
  • 425 funds tracked by Wall St. Rank held Chemed as of Q2 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2020, filed 13 Aug 2020.